istavel D

Introduction to Istavel D

Istavel D is a prescription medication designed to help manage blood sugar levels in individuals with type 2 diabetes. By combining two active ingredients, Dapagliflozin and Sitagliptin, Istavel D offers a dual approach to controlling blood glucose levels. This medication is typically used in conjunction with diet and exercise to improve glycemic control in adults. Available in tablet form, Istavel D provides a convenient option for those seeking to manage their diabetes effectively. It is important to use this medication under the guidance of a healthcare provider to ensure optimal results and minimize potential risks.

Composition of Istavel D

Istavel D contains two active ingredients: Dapagliflozin and Sitagliptin. Dapagliflozin, at a dose of 5mg, is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by preventing the kidneys from reabsorbing glucose back into the blood, thereby promoting the excretion of glucose through urine. This process helps to lower blood sugar levels. Sitagliptin, present at a dose of 50mg, is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It functions by increasing the levels of incretin hormones, which in turn stimulate insulin release and decrease glucagon levels in the bloodstream. Together, these ingredients help in maintaining better control over blood glucose levels.

Uses for Istavel D

• Improves glycemic control in adults with type 2 diabetes.
• Used as an adjunct to diet and exercise to manage blood sugar levels.
• May be prescribed when other medications do not provide adequate glycemic control.

Side Effects of Istavel D

• Urinary tract infections
• Upper respiratory tract infections
• Headache
• Hypoglycemia (when used with insulin or sulfonylureas)
• Back pain
• Nasopharyngitis

Precautions of Istavel D

Before starting Istavel D, inform your healthcare provider of any allergies, medical history, or current medications. This medication is not recommended for individuals with severe kidney impairment or those on dialysis. Monitor your blood sugar levels regularly and be aware of symptoms of low blood sugar, such as dizziness, sweating, and confusion. It is important to stay hydrated while taking this medication to prevent dehydration. Pregnant or breastfeeding women should consult their doctor before using Istavel D. Always follow your healthcare provider’s instructions and report any unusual symptoms or side effects promptly.

Conclusion

Istavel D is an effective medication for managing type 2 diabetes, combining the benefits of Dapagliflozin and Sitagliptin to help control blood sugar levels. Available in tablet form, it offers a practical solution for those seeking to improve their glycemic control. As with any medication, it is crucial to use Istavel D under medical supervision to maximize its benefits and minimize potential risks. By adhering to your healthcare provider’s guidance and maintaining a healthy lifestyle, Istavel D can be a valuable part of your diabetes management plan.